The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer

Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. C...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Qiao, Xin-wei, Jiang, Jian, Pang, Xin, Huang, Mei-chang, Tang, Ya-jie, Liang, Xin-hua, Tang, Ya-ling
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531035/
https://ncbi.nlm.nih.gov/pubmed/33072064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01721
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires